Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 5Colonic Neoplasms 4Adenocarcinoma 4Liver Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Neoplasm Metastasis 2Melanoma 2Esophageal Neoplasms 2Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Resectable Pancreatic Ductal Adenocarcinoma 1Prostatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Obesity 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasms 1Motor Activity 1Lymphatic Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Hepatitis C, Chronic 1Glioma 1

Interventions

Gemcitabine 13Albumin-Bound Paclitaxel 8Taxes 6130-nm albumin-bound paclitaxel 6Fluorouracil 5Oxaliplatin 4dehydroftorafur 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Leucovorin 3Irinotecan 3Losartan 2Cisplatin 2tocilizumab 1selicrelumab 1niraparib 1irinotecan sucrosofate 1indusatumab 1folfirinox 1durvalumab 1cobimetinib 1atezolizumab 1X-Rays 1Tiragolumab 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1S 1 (combination) 1Resistance Training 1Radiotherapy, Image-Guided 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Adenocarcinoma × Metformin × Gastrointestinal × Clear all
NCT02336087 2026-02-04

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

City of Hope Medical Center

Phase 1 Active not recruiting
21 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡